R3 Vascular Inc.

Cliff is a passionate visionary medical device senior leader with extensive experience in creating, building, and transforming research & development organizations in the USA, India, and China at a Fortune 500 company with over 200 engineers and multi-million USD R&D budgets. Cliff is highly skilled and recognized in leveraging innovative technologies to build product portfolios that generate sustained revenue growth. Karen is a collaborative strategic global business leader with extensive experience in New Product Development and Operations, building strong and effective diverse teams across organizations at all levels. Trusted advisor, recognized for successful process and program management, with a focus on leading complex initiatives and analyzing data and processes to identify solutions to increase organizational productivity and performance. Chandran's work on neurostimulation technology and EEG-based algorithms for personalized anesthesia medication delivery has translated well to the time series data and predictive analyses required for Smart Manufacturing and Structural Health Monitoring applications for IOT-OXYS, Inc.'s customers. William D’Agostino, PE, is a successful executive leader with more than 30 years of engineering, operational, and manufacturing experience focused on new product development concerning medical devices, biotech, and advanced technologies encompassing all aspects of launching and manufacturing new products. This includes engineering development, quality systems, risk management, and commercial manufacturing. Robert brings 25 year’s experience in medical device manufacturing, as well as experience in aerospace and commercial products industries.

Ahmad is a trained internist and clinical oncologist and brings over two decades of successful strategic clinical development, medical affairs, and marketing authorization expertise. Zocca brings more than 18 years of experience in the biotechnology field and has participated in the founding and co-founding of several biotech spinouts. Sullivan is a seasoned life sciences professional with more than 25 years of experience raising capital and building and managing corporate biotechnology and life sciences brands. Faulkner brings more than 25 years of technical operations, quality, and product launch experience within the biotechnology industry. Faulkner has experience in product development, manufacturing operations, supply chain, and commercialization of peptides, proteins, monoclonal antibodies, viruses, and combination products. Faulkner held senior roles at Homology Medicines as head of CMC management and external manufacturing, product operations lead for the Rare Disease Business Unit at Shire (Takeda), and spent over 15 years at Biogen involved in the development and commercialization of Avonex®, Tysabri®, and Tecfidera®. Dhingra is a medical oncologist and a physician-scientist with a proven track record in academic research, patient care, and drug development. Dhingra founded KAPital Consulting, LLC in 2008, a company dedicated to helping biotechnology, pharmaceutical, and diagnostic companies realize the clinical and commercial advances in oncology.

Our founders and medical advisors are among the worlds leading cardiologists with over 80 years of collective experience in interventional cardiology, PCI, TAVR, TMVR, and other complex procedures associated with cardiovascular disease. This team successfully developed and out-licensed med-tech interventional cardiology products to companies like Medtronics in the 1990s. Mauricio Cohen Medical Advisor 30 years of experience in interventional cardiology, complex PCI, TAVR, TMVR, and Mitral valve. Samir Pancholy Medical Advisor MD, FSCAI, over 25 years of experience in intervention cardiology. Raj Riswadkar CEO 20 years of experience growing startups for large-cap life sciences, and healthcare. Joe Korotko VP, Product Engineering Over 25 years of experience in inventing new products. Prior experience at Zimmer and leads manufacturing, QA/QC, RA, and IP. Christina Campbell Director Christina Campbell, DO, FACEP, is a business owner, investor, and entrepreneur with nearly 25 years experience in medicine in the fields of Emergency Medicine and Functional Medicine.

We are a start-up originally spun out of Dr. Dhivya is a passionate Entrepreneur with 15+ years experience in defining winning strategies and building high performance teams. Vergara has 14+ years of experience in experimental and computational biology. Shellard has a PhD and 12+ years of experience in cell biology and live imaging. Brian brings a track record of leading teams to deliver transformative results for clients across the healthcare sector at McKinsey and Company with particular focus on strategy / corporate finance, go-to-market, and M&A. Laghrissi is the CEO of DalCor Pharmaceuticals and has more than 20 years of pharmaceutical industry leadership experience, including roles at AstraZeneca, Roche, HBA and WPIC. Kupfer is the ex-Head of the DSM-5 plan committee, and has expert knowledge of the current principal manual for psychiatric & neurocognitive diagnosis, as recommended by the American Psychiatric Association. Linder is the CEO at Calciscon AG, biomedical consultant, entrepreneur & senior biotech executive with track record of success for biomedical devices.

CEO, Co-founder John Lee has over 35 years of experience in leading multiple companies worldwide. VP of CQR, Co-founder David Schlerf provides more than thirty-five years of Clinical, Quality and Regulatory expertise nationally and internationally. Successful regulatory submissions include IDE/PMA, 510(k), EU Technical Files (CE Mark), device registrations and marketing clearances within the EU and East Asia market sectors. Furthermore, John has over 30 years of experience in patent and taxation law. Executive Advisor Carl is a 34 year veteran of the medical device industry, with over 25 years dedicated to the orthopedic sector. Benjamin Song has more than 50 years of experience as orthopedic surgeon in the US. Song has expertise in join replacement surgery, bone fracture, osteoarthritis, arthroscopy, and carpal tunnel syndrome. Bruno Violante is a surgeon in orthopedic procedures with a particular attention to the advanced techniques of knee and hip surgery, in both sports and prosthetics.

Ayer is a neurosurgery attending with an MBA from the Kellogg School of Management at Northwestern University. Holcomb has over 20 years of experience leading medical device sales and marketing commercialization at 4 medical device startups from early stages through to 4 successful exits. Further, Holcomb previously developed an innovative digital DTC campaign, connecting interested patients to trained physicians. Julie Byars has spent nearly 15 years leading quality and regulatory teams at Medtronic Spine & Biologics, St. Mark Fisher is currently the Principal at Mission Product Development LLC.